NPI: 1003879461 · MURRIETA, CA 92562 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/07/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/07/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 16,924 | $527K |
| 2019 | 20,006 | $507K |
| 2020 | 18,632 | $626K |
| 2021 | 16,813 | $465K |
| 2022 | 14,378 | $407K |
| 2023 | 13,227 | $446K |
| 2024 | 8,223 | $344K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 34,012 | 2,900 | $3.20M |
| A4657 | Syringe, with or without needle, each | 3,883 | 2,038 | $111K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 33,477 | 2,126 | $9K |
| J1270 | Injection, doxercalciferol, 1 mcg | 15,254 | 1,298 | $1K |
| J1756 | Injection, iron sucrose, 1 mg | 8,027 | 1,969 | $616.66 |
| 85041 | 1,859 | 1,720 | $580.43 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 378 | 227 | $483.02 |
| 90662 | 27 | 26 | $48.05 | |
| 83970 | 1,359 | 1,281 | $0.00 | |
| 83540 | 920 | 849 | $0.00 | |
| 85048 | 1,838 | 1,700 | $0.00 | |
| 0250 | 4,505 | 291 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 52 | 51 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 581 | 557 | $0.00 |
| 82728 | 921 | 862 | $0.00 | |
| 83550 | 807 | 744 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 289 | 228 | $0.00 |
| 90674 | 14 | 14 | $0.00 |